Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.87 |
| ▸ | PPARG | P37231 | 6/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | PPARD | Q03181 | 5/20 | 0.63 |
| ▸ | PPARA | Q07869 | 5/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | FABP4 | P15090 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2511236 | 1.00 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL15323230 | 1.00 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL15377389 | 1.00 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL15335272 | 1.00 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL3754861 | 0.99 | MAPT (0.85) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL3754858 | 0.99 | MAPT (0.85) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL3752243 | 0.95 | MAPT (0.79) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL2508939 | 0.95 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL15335332 | 0.95 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL2508938 | 0.95 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117630349-A | Biomarkers associated with male reproductive dysfunction and uses thereof | 上海市生物医药技术研究院 | 2024-03-01 | — | — | CN | disclosed |
| US-20200200775-A1 | OXIDIZED LIPIDS AS BIOMARKERS FOR NEUROPATHIC PAIN | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2020-06-25 | — | — | US | disclosed |
| US-10322118-B2 | Compounds and methods for inhibiting Cif virulence factor | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2019-06-18 | — | — | US | disclosed |
| US-20160206605-A1 | COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-07-21 | — | — | US | disclosed |
| US-20150246075-A1 | METHODS FOR ENHANCING HEMATOPOIETIC STEM/PROGENITOR CELL ENGRAFTMENT | CHILDREN'S MEDICAL CENTER CORPORATION | 2015-09-03 | — | — | US | disclosed |
| US-20150246075-A1 | METHODS FOR ENHANCING HEMATOPOIETIC STEM/PROGENITOR CELL ENGRAFTMENT | CHILDREN'S MEDICAL CENTER CORPORATION | 2015-09-03 | — | — | US | disclosed |
| US-9056085-B2 | Methods for enhancing hematopoietic stem/progenitor cell engraftment | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2015-06-16 | — | — | US | disclosed |
| US-9056085-B2 | Methods for enhancing hematopoietic stem/progenitor cell engraftment | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2015-06-16 | — | — | US | disclosed |
| US-20150045389-A1 | COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-02-12 | — | — | US | disclosed |
| WO-2013155047-A2 | COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2013-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246075-A1 | METHODS FOR ENHANCING HEMATOPOIETIC STEM/PROGENITOR CELL ENGRAFTMENT | HCLS1, MCL1, THPO | MAPT 4738/4885PPARG 2546/4885ALDH1A1 92/4885 |
| US-20160206605-A1 | COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR | CFTR, NCF1, CFB | MAPT 4882/4885PPARG 3326/4885ALDH1A1 3655/4885 |
| US-10322118-B2 | Compounds and methods for inhibiting Cif virulence factor | CFTR, NCF1, CFB | MAPT 4882/4885PPARG 3326/4885ALDH1A1 3655/4885 |
| US-20150045389-A1 | COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR | CFTR, NCF1, CFB | MAPT 4882/4885PPARG 3180/4885ALDH1A1 3767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.